Lim LL - Search Results

1

The Influence of Intravitreal Ranibizumab on Inflammation-associated Cytokine Concentrations in Eyes With Diabetic Macular Edema.

Lim SW, Bandala-Sanchez E, Kolic M, Rogers SL, McAuley AK, Lim LL, Wickremasinghe SS. Lim SW, et al. Among authors: lim ll. Invest Ophthalmol Vis Sci. 2018 Nov 1;59(13):5382-5390. doi: 10.1167/iovs.17-23325. Invest Ophthalmol Vis Sci. 2018. PMID: 30452591

2

The prevalence of retinal vein occlusion: pooled data from population studies from the United States, Europe, Asia, and Australia.

Rogers S, McIntosh RL, Cheung N, Lim L, Wang JJ, Mitchell P, Kowalski JW, Nguyen H, Wong TY; International Eye Disease Consortium. Rogers S, et al. Ophthalmology. 2010 Feb;117(2):313-9.e1. doi: 10.1016/j.ophtha.2009.07.017. Ophthalmology. 2010. PMID: 20022117 Free PMC article.

3

Changes in vision- and health-related quality of life in patients with diabetic macular edema treated with pegaptanib sodium or sham.

Loftus JV, Sultan MB, Pleil AM; Macugen 1013 Study Group. Loftus JV, et al. Invest Ophthalmol Vis Sci. 2011 Sep 29;52(10):7498-505. doi: 10.1167/iovs.11-7613. Invest Ophthalmol Vis Sci. 2011. PMID: 21896838 Clinical Trial.

4

Two-year safety and efficacy of ranibizumab 0.5 mg in diabetic macular edema: interim analysis of the RESTORE extension study.

Lang GE, Berta A, Eldem BM, Simader C, Sharp D, Holz FG, Sutter F, Gerstner O, Mitchell P; RESTORE Extension Study Group. Lang GE, et al. Ophthalmology. 2013 Oct;120(10):2004-12. doi: 10.1016/j.ophtha.2013.02.019. Epub 2013 May 29. Ophthalmology. 2013. PMID: 23725735 Clinical Trial.

5

Use of intravitreal rituximab for treatment of vitreoretinal lymphoma.

Larkin KL, Saboo US, Comer GM, Forooghian F, Mackensen F, Merrill P, Sen HN, Singh A, Essex RW, Lake S, Lim LL, Vasconcelos-Santos DV, Foster CS, Wilson DJ, Smith JR. Larkin KL, et al. Among authors: lim ll. Br J Ophthalmol. 2014 Jan;98(1):99-103. doi: 10.1136/bjophthalmol-2013-304043. Epub 2013 Oct 24. Br J Ophthalmol. 2014. PMID: 24158837

6

Three-year outcomes of individualized ranibizumab treatment in patients with diabetic macular edema: the RESTORE extension study.

Schmidt-Erfurth U, Lang GE, Holz FG, Schlingemann RO, Lanzetta P, Massin P, Gerstner O, Bouazza AS, Shen H, Osborne A, Mitchell P; RESTORE Extension Study Group. Schmidt-Erfurth U, et al. Ophthalmology. 2014 May;121(5):1045-53. doi: 10.1016/j.ophtha.2013.11.041. Epub 2014 Feb 1. Ophthalmology. 2014. PMID: 24491642 Free article. Clinical Trial.

7

Intravitreal aflibercept for macular edema secondary to central retinal vein occlusion: 18-month results of the phase 3 GALILEO study.

Ogura Y, Roider J, Korobelnik JF, Holz FG, Simader C, Schmidt-Erfurth U, Vitti R, Berliner AJ, Hiemeyer F, Stemper B, Zeitz O, Sandbrink R; GALILEO Study Group. Ogura Y, et al. Am J Ophthalmol. 2014 Nov;158(5):1032-8. doi: 10.1016/j.ajo.2014.07.027. Epub 2014 Jul 25. Am J Ophthalmol. 2014. PMID: 25068637 Clinical Trial.

8

A randomized clinical trial of intravitreal bevacizumab versus intravitreal dexamethasone for diabetic macular edema: the BEVORDEX study.

Gillies MC, Lim LL, Campain A, Quin GJ, Salem W, Li J, Goodwin S, Aroney C, McAllister IL, Fraser-Bell S. Gillies MC, et al. Among authors: lim ll. Ophthalmology. 2014 Dec;121(12):2473-81. doi: 10.1016/j.ophtha.2014.07.002. Epub 2014 Aug 22. Ophthalmology. 2014. PMID: 25155371 Clinical Trial.

9

Outcomes of persistently active neovascular age-related macular degeneration treated with VEGF inhibitors: observational study data.

Barthelmes D, Walton R, Campain AE, Simpson JM, Arnold JJ, McAllister IL, Guymer RH, Hunyor AP, Essex RW, Morlet N, Gillies MC; Fight Retinal Blindness! Project Investigators. Barthelmes D, et al. Br J Ophthalmol. 2015 Mar;99(3):359-64. doi: 10.1136/bjophthalmol-2014-305514. Epub 2014 Sep 23. Br J Ophthalmol. 2015. PMID: 25249615 Free article.

10

Two-year outcomes of "treat and extend" intravitreal therapy for neovascular age-related macular degeneration.

Arnold JJ, Campain A, Barthelmes D, Simpson JM, Guymer RH, Hunyor AP, McAllister IL, Essex RW, Morlet N, Gillies MC; Fight Retinal Blindness Study Group. Arnold JJ, et al. Ophthalmology. 2015 Jun;122(6):1212-9. doi: 10.1016/j.ophtha.2015.02.009. Epub 2015 Apr 4. Ophthalmology. 2015. PMID: 25846847

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

400 results

Search Page

Filters